Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

AML - 917

Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

Harsha Pattnaik

Poster Presenter: Harsha Pattnaik

Thumbnail for Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

Previous 1...22 23 24 25 26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 920

Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

Cesar Copaja-Corzo

Poster Presenter: Cesar Copaja-Corzo

$Thumbnail for Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis$

AML - 923

Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis

Bhaswanth Bollu

Poster Presenter: Bhaswanth Bollu

Thumbnail for Phase A of the F-A-A Study: Derivation of a Bedside Functional Assessment-Age-Albumin Score for Predicting Induction Mortality in Patients With AML Receiving Low-Intensity Venetoclax-Based Therapy

AML - 927

Phase A of the F-A-A Study: Derivation of a Bedside Functional Assessment-Age-Albumin Score for Predicting Induction Mortality in Patients With AML Receiving Low-Intensity Venetoclax-Based Therapy

Rudra Narayan Swain

Poster Presenter: Rudra Narayan Swain

Thumbnail for Real-World Outcomes of Acute Myeloid Leukemia, Myelodysplasia-Related: A Single Centre Study from Pakistan

AML - 941

Real-World Outcomes of Acute Myeloid Leukemia, Myelodysplasia-Related: A Single Centre Study from Pakistan

Maryam Khan

Poster Presenter: Maryam Khan

Thumbnail for Survival Outcomes in Relation to EBMT Risk Score in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Low- and Middle-Income Countries

AML - 946

Survival Outcomes in Relation to EBMT Risk Score in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Low- and Middle-Income Countries

Maryam Khan

Poster Presenter: Maryam Khan

Thumbnail for A 25-Year Analysis of Leukemia and Hypertensive Disease Co-Mortality Among Older Adults in the United States, 1999-2024

AML - 947

A 25-Year Analysis of Leukemia and Hypertensive Disease Co-Mortality Among Older Adults in the United States, 1999-2024

Nuri Tamanna

Poster Presenter: Nuri Tamanna

Thumbnail for Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort

AML - 949

Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort

Mayank Soni

Poster Presenter: Mayank Soni

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors